Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tommaso Toffanin has a total of 126 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Demoralization and Mental Disorders in Community-Dwelling Older Adults: Cluster Analysis

    by Alice Onofrio, Maria Ferrara, Ilaria Domenicano, Martino Belvederi Murri, Tommaso Toffanin, Maria Giulia Nanni, Alessandra Canuto, Kerstin Weber, Jana Volkert, Holger Schulz, et al.

    Background: Demoralization negatively affects the quality of life, especially in people with mental disorders. Objective: This study aims to assess demoralization in a cohort of community-dwelling older adults, to identify groups of individuals who share similar characteristics in terms of mental health conditions and the severity of demoralization domains, and to investigate the different characteristics across these groups. Methods: Participants were enrolled in 3 centers as part of the cross-sectional MentDis_ICF65+ study and were assessed using the Demoralization Scale and the Composite International Diagnostic Interview at baseline. A cluster analysis was conducted using the partitioning around medoids algorithm with Gower’s distance to classify individuals based on demoralization severity and the diagnosis of mental health disorders, allocating individuals to a distinct number of patterns by examining their similarities across these variables. Results: Among the final sample of 1369 participants, 3 clusters were identified: the “low psychopathology” cluster, with very few mental health diagnoses; the “affective” cluster, characterized by affective disorders (100% of participants); and the “anxiety” cluster, characterized by anxiety disorders (100% of participants). Men were prevalent in the “low psychopathology” cluster (n=635, 59.1%; P <.001), while women were more prevalent in the “affective” cluster (n=133, 72.3%; P <.001) and the “anxiety” cluster (n=79, 71.8%; P <.001). The “affective” cluster had the highest mean scores for disheartenment (17.1, SD 6.7; P <.001), dysphoria (12.1, SD 3.5; P <.001), and loss of meaning (11.8, SD 4.9; P <.001) but the lowest for sense of failure (17.4, SD 3.2; P <.001). Conclusions: The identification of different clusters of demoralization and mental health disorders in community-dwelling older adults, as well as sex-based differences, highlights the need for tailored mental health interventions in this vulnerable population.

  • Corrigendum to “Depression and psycho-existential correlates in cancer outpatients: A longitudinal real-life study” Journal of Psychosomatic Research, Volume 209, October 2026, 112886

    by Rosangela Caruso, Marco Cruciata, Maria Giulia Nanni, Martino Belvederi Murri, Luigi Zerbinati, Stefano Tugnoli, Ester Allegro, Marina Pantuso, Klaudio Shakaj, Tommaso Toffanin, et al.

  • Open Access

    Depression and psycho-existential correlates in cancer outpatients: A longitudinal real-life study

    by Rosangela Caruso, Marco Cruciata, Maria Giulia Nanni, Martino Belvederi Murri, Luigi Zerbinati, Stefano Tugnoli, Ester Allegro, Marina Pantuso, Klaudio Shakaj, Tommaso Toffanin, et al.

  • Open Access

    Human-Derived Cellular Models in Psychiatry: A Focus on the Olfactory Neuroepithelium

    by Tommaso Toffanin, Mario Angelo Pagano, Carlo Idotta, Luigi Grassi, Anna Maria Brunati

    Severe mental disorders, including schizophrenia (SCZ), bipolar disorder (BD), and major depressive disorder (MDD), are leading causes of global disability, yet current treatments remain largely symptomatic and fail to alter disease trajectories. Converging evidence from genetics, longitudinal studies, and systems neuroscience supports a dimensional and transdiagnostic architecture of psychopathology, involving shared polygenic risk and overlapping neurodevelopmental and circuit-level alterations. Traditional approaches—such as post-mortem brain analysis, neuroimaging, and animal models—have delineated core molecular perturbations (e.g., dopaminergic, glutamatergic, and GABAergic dysfunction), as well as informed translational frameworks for mechanistic investigation, but remain constrained by restricted access to dynamic processes and incomplete recapitulation of human-specific biology. The advent of human-derived cellular models, particularly human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs), has partially addressed these limitations, enabling the study of patient-specific neurodevelopment and synaptic function in vitro. Within this evolving landscape, the olfactory neuroepithelium (ONE) has emerged as an accessible source of neural progenitors, obtainable through minimally invasive procedures, providing a window into living human neurobiology. ONE-derived cells retain donor-specific genetic and epigenetic signatures while recapitulating disease-relevant phenotypes across major psychiatric disorders, including altered neurodevelopmental dynamics, synaptic gene expression, and inflammatory profiles. Here, we present a narrative review of the principal cellular and tissue models used in biological psychiatry, examining their respective strengths, limitations, and translational relevance across experimental contexts. By situating these approaches within a unified framework, we aim to clarify their complementarity, identify current gaps, and outline future directions, highlighting the emerging potential of ONE-based models to bridge genetic risk, cellular dysfunction, and clinical phenotype, thereby advancing precision psychiatry.

  • Open Access

    FRIDA: A Four-Factor Adaptive Screening Tool for Demoralization, Anxiety, Irritability, and Depression in Hospital Patients

    by Martino Belvederi Murri, Angela Muscettola, Michele Specchia, Chiara Montemitro, Luigi Zerbinati, Marco Cruciata, Tommaso Toffanin, Guido Sciavicco, Rosangela Caruso, Federica Sancassiani, et al.

    Background: Demoralization, anxiety, irritability, and depression are common among hospital patients and are associated with poorer outcomes and greater healthcare burden. Early identification is essential, but simultaneous screening across multiple domains is often impractical with questionnaires. Computerized Adaptive Testing (CAT) offers a solution by tailoring item administration, reducing test length while preserving measurement precision. The aim of this study was to develop and validate FRIDA (Four-factor Rapid Interactive Diagnostic Assessment), a freely accessible, web-based CAT for rapid multidimensional screening of psychopathology in hospital patients. Methods: We analysed data from 472 medically ill in-patients at a University Hospital. Item calibration was performed using a four-factor graded response model (demoralization, anxiety, irritability, depression) in the mirt package. CAT simulations were run with 1000 virtual respondents to optimize item selection, exposure control, and stopping rules. The best configuration was applied to the real dataset. Criterion validity for demoralization was evaluated against the Diagnostic Criteria for Psychosomatic Research (DCPR). Results: The four-factor model showed good fit (CFI = 0.947, RMSEA = 0.080). Factor correlations were moderate to high, with the strongest overlap between demoralization and depression (r = 0.93). In simulations, the CAT required, on average, 7.8 items and recovered trait estimates with high accuracy (r = 0.94–0.97). In real patients, mean test length was 11 items, with accuracy of r = 0.95 across domains. FRIDA demonstrated good criterion validity for demoralization (AUC = 0.816; sensitivity 80%, specificity 67.5%). Conclusions: FRIDA is the first freely available, multidimensional CAT for rapid screening of psychopathology in hospital patients. It offers a scalable, efficient, and precise tool for integrating mental health assessment into routine hospital care.


  • Neural stem/progenitor cells from olfactory neuroepithelium collected by nasal brushing as a cell model reflecting molecular and cellular dysfunctions in schizophrenia

    by Carlo Idotta, Mario Angelo Pagano, Elena Tibaldi, Massimiliano Cadamuro, Roberto Saetti, Marina Silvestrini, Giorgio Pigato, Luigi Leanza, Roberta Peruzzo, Leonardo Meneghetti, et al.

    Neural stem/progenitor cells derived from olfactory neuroepithelium (hereafter olfactory neural stem/progenitor cells, ONSPCs) are emerging as a potential tool in the exploration of psychiatric disorders. The present study intended to assess whether ONSPCs could help discern individuals with schizophrenia (SZ) from non-schizophrenic (NS) subjects by exploring specific cellular and molecular features. ONSPCs were collected from 19 in-patients diagnosed with SZ and 31 NS individuals and propagated in basal medium. Mitochondrial ATP production, expression of β-catenin and cell proliferation, which are described to be altered in SZ, were examined in freshly isolated or newly thawed ONSPCs after a few culture passages. SZ-ONSPCs exhibited a lower mitochondrial ATP production and insensitivity to agents capable of positively or negatively affecting β-catenin expression with respect to NS-ONSPCs. As to proliferation, it declined in SZ-ONSPCs as the number of culture passages increased compared to a steady level of growth shown by NS-ONSPCs. The ease and safety of sample collection as well as the differences observed between NS- and SZ-ONSPCs, may lay the groundwork for a new approach to obtain biological material from a large number of living individuals and gain a better understanding of the mechanisms underlying SZ pathophysiology.


  • Open Access

    The screen for cognitive impairment in psychiatry in patients with borderline personality disorder

    by Federica Folesani, Martino Belvederi Murri, Bruno Biancosino, Silvia Costa, Luigi Zerbinati, Rosangela Caruso, Maria Giulia Nanni, Tommaso Toffanin, Maria Ferrara, Scot E. Purdon, et al.

    Cognitive deficits are common in borderline personality disorder (BPD) and appear to be associated with psychopathology, functioning and outcome. The availability of a cognitive screening instrument could be of use in clinical settings in order to assess neurocognition in BPD patients. The Screen for Cognitive Impairment for Psychiatry (SCIP) proved to be reliable in different psychiatric populations, but it has not yet been validated in personality disorders. The purpose of this study is therefore to evaluate its psychometric properties in a sample of 58 BPD patients. The SCIP was validated against the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and the Trail Making Test A and B (TMT A and B). The receiver operator curve analysis displayed an acceptable convergent validity (total score AUC: 0.78, 95% CI: 0.70–0.86; Se: 75%, Sp: 72%). A cut‐off total score of 80 identified 81% of patients as cognitively impaired. The exploratory factor analysis displayed a one‐factor solution explaining 55.8% of the total variance. The SCIP displayed adequate psychometric properties in BPD and could be integrated in the routine clinical assessment to provide a preliminary evaluation of cognitive features for BPD.


  • Long-Acting Aripiprazole in the Management of Violence in Treatment Nonadherent Schizophrenia

    by Tommaso Toffanin, Alessandro Miola, Benedetta Salvati, Francesco Folena Comini, Chiara Pavan, Giorgio Pigato, Fabio Sambataro


  • Psychosis in Patients in COVID-19–Related Quarantine

    by Francesco Finatti, Giorgio Pigato, Chiara Pavan, Tommaso Toffanin, Angela Favaro


  • A Case Report of Neurosyphilis Limbic Encephalitis With Reversible Geschwind Syndrome and Mood Disorder

    by Tommaso Toffanin, Alessandro Miola, Halima Follador, Giovanni Ferri, Nadia Scupola, Nicola Martino, Alessandra Baratto, Giulia Ida Perini

    Limbic encephalitis is an inflammatory process of the limbic structures, with polymorphic clinical features, caused by paraneoplastic and nonparaneoplastic conditions and infections. We describe a case of neurosyphilis limbic encephalitis, presenting with reversible Geschwind syndrome (hyperreligiosity and hypergraphia) and mood disorder due to the predominant involvement of left mesial temporal structures in a previously healthy 34-year-old, left-handed woman. Because neurosyphilis can mimic common neuropsychiatric syndromes, it should be included in the differential diagnosis of psychiatric disorders with suspected general medical causes. This case of nondominant limbic encephalopathy caused by syphilis infection highlights the relevance of a careful investigation for secondary psychotic, mood, and personality disorders when assessing new-onset psychiatric illness and the importance of a multidisciplinary approach to provide a better outcome in patients with neurosyphilis.